Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 2Gliosarcoma 2Glioblastoma 2Ependymoma 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Astrocytoma 2Precancerous Conditions 1Pinealoma 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Multiple Sclerosis 1Meningioma 1Medulloblastoma 1Liver Neoplasms 1Glioma 1Choroid Plexus Neoplasms 1

Interventions

Carboplatin 3Vincristine 2Radiotherapy 2Etoposide 2Cyclophosphamide 2palbociclib 1gadobutrol 1gadobenic acid 1etoposide phosphate 1Yoga 1Topotecan 1Temozolomide 1Surgical Procedures, Operative 1Semaxinib 1Microarray Analysis 1Methotrexate 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Immunohistochemistry 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Gadolinium DTPA 1Filgrastim 1Doxorubicin 1Dexamethasone 1Dasatinib 1Dactinomycin 1Cyproheptadine 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Choroid Plexus Neoplasms × Gadolinium DTPA × Clear all
NCT02967380 2017-03-27

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

University of Southern California

Phase NA Terminated
14 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Multiple Sclerosis, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡